DocuSign, Inc. — FY2024 Form 10-K
Business context and reporting period. This annual report covers the fiscal year ended January 31, 2024 (FY2024), with comparisons primarily to FY2023. DocuSign sells subscription-based e-signature and agreement workflow products, including contract lifecycle management (CLM). Subscriptions generated 97% of revenue. The company reported more than 1.5 million customers and over one billion users; no customer represented more than 10% of revenue.
Financial performance and liquidity
| Metric | FY2024 | FY2023 |
|---|---|---|
| Revenue | $2.762 billion | $2.516 billion |
| GAAP gross margin | 79% | 79% |
| Income (loss) from operations | $31.6 million | $(88.0) million |
| Net income (loss) | $74.0 million | $(97.5) million |
| Cash from operating activities | $979.5 million | $506.8 million |
| Free cash flow, company-defined | $887.1 million | $429.1 million |
- Revenue rose 10%; subscription revenue increased 10% to $2.687 billion, while professional services and other revenue rose 2% to $75.2 million. International revenue was 26% of total, up from 25%.
- GAAP operating margin improved to 1% from negative 3%. Net income also benefited from $68.9 million of interest and other income, up from $4.5 million, primarily reflecting higher interest income and investment accretion.
- Stock-based compensation was $616.8 million, a substantial expense relative to GAAP operating income. Company-reported non-GAAP operating income was $711.4 million, with a 26% margin; these measures exclude specified items and are not GAAP results.
- Capital expenditures were $92.4 million. Cash, cash equivalents and investments totaled approximately $1.167 billion at year-end; cash and cash equivalents alone were $797.1 million.
- The company repaid approximately $727.0 million of convertible notes during FY2024. No borrowings were outstanding under its $500 million revolving credit facility, which matures in January 2026; the company reported compliance with debt covenants. Operating lease liabilities totaled $143.1 million.
Material changes versus FY2023
- Revenue growth was accompanied by a return to GAAP operating and net income from losses in FY2023. Operating cash flow increased by $472.8 million.
- Sales and marketing expense fell 6% to $1.168 billion, primarily reflecting restructuring-related personnel savings and lower paid-media spending. R&D expense rose 12% to $539.5 million and general and administrative expense rose 33% to $419.6 million, with increases including stock compensation, personnel and technology costs.
- Operating expenses increased overall to $2.158 billion from $2.068 billion. FY2024 included $30.4 million of restructuring charges, compared with $28.3 million in FY2023.
- Financing cash outflows increased to $946.0 million, principally due to repayment of convertible notes, $145.5 million of share repurchases, and tax withholding on equity awards.
Outlook, commentary, risks and unusual items
- The filing provides no quantified revenue or earnings guidance. Management describes continued investment in product innovation, AI, customer expansion, self-service sales and international growth. Remaining performance obligations for contracts longer than one year were $2.2 billion; 56% was expected to be recognized in the following 12 months.
- In February 2024, DocuSign announced a further restructuring expected to reduce its workforce by approximately 6%, primarily in Sales and Marketing. It estimated charges of $28–$32 million, mostly in FY2025, with completion expected by the end of FY2025’s second quarter.
- Key business risks include reliance on eSignature, competition (including Adobe), customer renewal and expansion, macroeconomic pressure on spending, cybersecurity and data privacy, service availability, and execution of product and AI initiatives. The filing also cites leadership transitions and the challenge of managing restructuring and growth.
- Pending matters include a securities class action and related derivative litigation, as well as an arbitration brought by former CEO Daniel Springer. The arbitration hearing occurred in March 2024; a final order was expected by June 30, 2024. Management stated it did not believe the disclosed matters would have a material adverse effect, but outcomes remain uncertain.
- The independent auditor gave unqualified opinions on the financial statements and internal control over financial reporting; management also concluded controls were effective. Revenue recognition, particularly evaluation of contract terms, was identified as a critical audit matter.
Important facts for investors to verify
- Whether revenue growth, renewals and customer expansion continue, particularly given the company’s dependence on eSignature and the decline in customers with more than $300,000 of annualized contract value (1,060 versus 1,080).
- How much of reported profitability and cash generation is sustainable, considering $616.8 million of stock-based compensation and the contribution of interest income to FY2024 net income.
- Execution and costs of the announced workforce reduction, and whether it affects sales capacity, product development or customer support.
- Developments and potential financial exposure in the securities, derivative and former-CEO legal matters.
- Use of cash for repurchases and the remaining authorization (approximately $291.5 million at year-end), alongside investment needs and deferred revenue obligations.